FDA hearing highlights opposition to dietary supplement practices; written comments due August 20. Food and Drug Administration.
James
J S
JS
D019587:Dietary Supplements; D004348:Drug Labeling; D006801:Humans; D007880:Legislation, Drug; D011639:Public Opinion; D014486:United States Food and Drug Administration